Compare HERZ & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HERZ | XCUR |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 26.6M |
| IPO Year | N/A | 2017 |
| Metric | HERZ | XCUR |
|---|---|---|
| Price | $18.14 | $3.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 9.5K |
| Earning Date | N/A | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.62 | $3.10 |
| 52 Week High | $19.30 | $11.00 |
| Indicator | HERZ | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 35.92 |
| Support Level | $13.85 | $3.15 |
| Resistance Level | $19.30 | $4.23 |
| Average True Range (ATR) | 0.86 | 0.19 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 74.82 | 21.67 |
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.